DOW

Dow Inc. 2025 Q2 10-Q Filing Summary

Business Context and Reporting Period

This is a combined Form 10-Q for Dow Inc. and its wholly-owned subsidiary, The Dow Chemical Company (TDCC), for the quarterly period ended June 30, 2025. Dow operates as a global materials science company with three primary operating segments: Packaging & Specialty Plastics, Industrial Intermediates & Infrastructure, and Performance Materials & Coatings. The reporting period reflects a challenging macroeconomic environment characterized by slower global GDP growth, industry overcapacity, and geopolitical volatility.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 7% in Q2 2025 compared to Q2 2024, driven by a 7% decrease in local price and a 1% decrease in volume. All geographic regions and operating segments reported sales declines.
• Significant Restructuring Charges: The Company recorded $591 million in pretax restructuring and asset-related charges in Q2 2025. This includes $334 million in asset write-downs/write-offs, $154 million in severance, and $103 million in exit/disposal costs. These charges relate to a new program approved June 30, 2025, to rationalize the global asset footprint, including shutdowns in Germany and the UK.
• Profitability Impact: The combination of lower margins, volume declines, and significant restructuring charges resulted in a net loss of $835 million for Dow Inc. in Q2 2025, compared to a net income of $439 million in the prior year period.
• Divestitures: The Company sold its soil fumigation product line (Telone) for $121 million in net cash proceeds and announced the sale of its 50% interest in DowAksa for approximately $125 million (expected to close Q3 2025).
• Infrastructure Sale: On May 1, 2025, Dow sold 40% of its membership interest in Diamond Infrastructure Solutions for approximately $2.4 billion in cash proceeds.

Guidance, Outlook, and Risks

• Capital Expenditure Reduction: Management reduced the full-year 2025 capital expenditure guidance to $2.5 billion (down from $3.5 billion), primarily due to the decision to delay the Path2Zero project in Fort Saskatchewan, Alberta, until market conditions improve.
• Dividend Adjustment: On July 24, 2025, the Board declared a quarterly dividend of $0.35 per share, a 50% reduction from the previous $0.70 per share, reflecting the prolonged industry downturn and a balanced capital allocation approach.
• Outlook: Management expects challenging macroeconomic conditions, including slower GDP growth and industry overcapacity, to persist in the near term. The Company is actively monitoring global trade developments and tariff policies.
• Risks: Key risks include geopolitical conflicts (Russia/Ukraine, Middle East), trade policy uncertainty, supply chain disruptions, and the impact of anti-competitive economics from new market entrants. Credit rating agencies have revised outlooks to negative (Moody's downgraded TDCC to Baa2).

Investor Verification Checklist

• Restructuring Execution: Verify the timeline and cash impact of the $591 million restructuring program, specifically the shutdown of assets in Böhlen and Schkopau, Germany, and Barry, UK.
• Dividend Sustainability: Assess the long-term implications of the 50% dividend cut on shareholder returns and the Company's commitment to its 65% Operating Net Income payout target over the economic cycle.
• Path2Zero Project Status: Monitor the decision-making process regarding the delayed Path2Zero project and the criteria for resuming construction.
• Working Capital Trends: Review the continued pressure on working capital, evidenced by negative operating cash flow in the first half of 2025.
• Legal Contingencies: Track the status of the $1.2 billion judgment against Nova Chemicals Corporation and the potential for appeals or collection delays.